AIM &OBJECTIVE: To evaluate and compare the immediate loco regional response rates in locally advanced squamous cell carcinomas of the head and neck treated with low dose daily Cisplatin versus weekly Cisplatin concurrently with accelerated radiation and also to assess and compare the acute toxicity in both arms. MATERIALS AND METHODS: This double arm prospective study was conducted in dept of radiotherapy, MMC between October 2016 to august 2017 with sample Size of 30 patients in each arm in Stage 3 &4 locally advanced head and Cancers with squamous histology excluding nasal cavity and nasopharynx patients. The mean age of the patient was around 50 years, mostly males with ECOG status 0-1. Arm 1 was given low dose daily Cisplatin 6 mg...
65% patients with head and neck tumors present with locally advanced disease. Concurrent chemo radi...
BACKGROUND: Three-weekly high-dose cisplatin (100 mg/m2) is considered the standard systemic regime...
In developing countries most of the cervical cancer presents in advanced stage of disease Improving ...
AIMS & OBJECTIVES: To assess the immediate loco regional response rates and acute toxicity in patie...
Background: Concurrent chemo radiation is standard of care in locally advanced squamous cell carcino...
AIMS & OBJECTIVES: To assess the immediate loco regional response rates and to assess the toxicity...
Background: Head and neck cancers constitute 6% of cancers worldwide. The management requires a mult...
Aim: This was a prospective two arm comparative study of quality of life, toxicity and response in p...
AIMS: In this retrospective analysis, we describe the efficacy and tolerability of weekly cisplatin...
INTRODUCTION: Carcinoma cervix is the most common gynaecological malignancy in women. Concurrent ch...
Objectives: To compare cumulative cisplatin dose and toxicity between patients who received 3-weekly...
Background: The purpose of this study was to compare the role of concomitant chemoradiation using pa...
SummaryObjectivesTo compare cumulative cisplatin dose and toxicity between patients who received 3-w...
Oral cavity cancer constitutes two thirds of locally advanced head and neck cancer in India and ma...
Jérôme Fayette,1 Yann Molin,1 Emilie Lavergne,2 Xavier Montbarbon,3 Séverine Rac...
65% patients with head and neck tumors present with locally advanced disease. Concurrent chemo radi...
BACKGROUND: Three-weekly high-dose cisplatin (100 mg/m2) is considered the standard systemic regime...
In developing countries most of the cervical cancer presents in advanced stage of disease Improving ...
AIMS & OBJECTIVES: To assess the immediate loco regional response rates and acute toxicity in patie...
Background: Concurrent chemo radiation is standard of care in locally advanced squamous cell carcino...
AIMS & OBJECTIVES: To assess the immediate loco regional response rates and to assess the toxicity...
Background: Head and neck cancers constitute 6% of cancers worldwide. The management requires a mult...
Aim: This was a prospective two arm comparative study of quality of life, toxicity and response in p...
AIMS: In this retrospective analysis, we describe the efficacy and tolerability of weekly cisplatin...
INTRODUCTION: Carcinoma cervix is the most common gynaecological malignancy in women. Concurrent ch...
Objectives: To compare cumulative cisplatin dose and toxicity between patients who received 3-weekly...
Background: The purpose of this study was to compare the role of concomitant chemoradiation using pa...
SummaryObjectivesTo compare cumulative cisplatin dose and toxicity between patients who received 3-w...
Oral cavity cancer constitutes two thirds of locally advanced head and neck cancer in India and ma...
Jérôme Fayette,1 Yann Molin,1 Emilie Lavergne,2 Xavier Montbarbon,3 Séverine Rac...
65% patients with head and neck tumors present with locally advanced disease. Concurrent chemo radi...
BACKGROUND: Three-weekly high-dose cisplatin (100 mg/m2) is considered the standard systemic regime...
In developing countries most of the cervical cancer presents in advanced stage of disease Improving ...